CN100516018C - 双酯 - Google Patents

双酯 Download PDF

Info

Publication number
CN100516018C
CN100516018C CNB028232739A CN02823273A CN100516018C CN 100516018 C CN100516018 C CN 100516018C CN B028232739 A CNB028232739 A CN B028232739A CN 02823273 A CN02823273 A CN 02823273A CN 100516018 C CN100516018 C CN 100516018C
Authority
CN
China
Prior art keywords
group
bis
compound
ethyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028232739A
Other languages
English (en)
Chinese (zh)
Other versions
CN1589254A (zh
Inventor
乔·克拉夫尼斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Photocure ASA
Original Assignee
Photocure ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure ASA filed Critical Photocure ASA
Publication of CN1589254A publication Critical patent/CN1589254A/zh
Application granted granted Critical
Publication of CN100516018C publication Critical patent/CN100516018C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/50—Sebacic acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/44—Adipic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/48—Azelaic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/96—Esters of carbonic or haloformic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
  • Tires In General (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CNB028232739A 2001-11-22 2002-11-22 双酯 Expired - Fee Related CN100516018C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0128052.8 2001-11-22
GBGB0128052.8A GB0128052D0 (en) 2001-11-22 2001-11-22 Compounds

Publications (2)

Publication Number Publication Date
CN1589254A CN1589254A (zh) 2005-03-02
CN100516018C true CN100516018C (zh) 2009-07-22

Family

ID=9926289

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028232739A Expired - Fee Related CN100516018C (zh) 2001-11-22 2002-11-22 双酯

Country Status (15)

Country Link
US (1) US7629383B2 (enExample)
EP (1) EP1448508B1 (enExample)
JP (1) JP4426298B2 (enExample)
KR (1) KR20040071138A (enExample)
CN (1) CN100516018C (enExample)
AT (1) ATE443695T1 (enExample)
AU (1) AU2002343086C1 (enExample)
CA (1) CA2467773C (enExample)
DE (1) DE60233819D1 (enExample)
GB (1) GB0128052D0 (enExample)
HU (1) HUP0402122A2 (enExample)
MX (1) MXPA04004763A (enExample)
NO (1) NO20042603L (enExample)
RU (1) RU2350599C2 (enExample)
WO (1) WO2003045893A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
DE102006004804A1 (de) * 2006-01-23 2007-07-26 Intendis Gmbh Verwendung von Alkandicarbonsäuren und Retinoiden zur Behandlung entzündlicher Hauterkrankungen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4462934A (en) 1983-03-31 1984-07-31 Pfizer Inc. Bis-esters of dicarboxylic acids with amoxicillin and certain hydroxymethylpenicillanate 1,1-dioxides
GB8310080D0 (en) * 1983-04-14 1983-05-18 Interox Chemicals Ltd Bleach composition
DE3465334D1 (en) 1983-04-14 1987-09-17 Interox Chemicals Ltd Peroxygen compounds
ATE74359T1 (de) * 1987-01-27 1992-04-15 Pfizer 6-beta(substituierte)-(s)hydroxymethylpenicillans|ure und deren derivate.
LU86918A1 (fr) * 1987-06-12 1989-03-08 Oreal Nouveaux diesters de l'acide azelaique,leur procede de preparation,les compositions topiques les contenant et leur utilisation dans le traitement de l'acne
EP0577659B1 (en) 1991-03-28 1996-01-17 Nycomed Imaging As Cross-linking agent
CZ284844B6 (cs) 1992-03-06 1999-03-17 Nycomed Imaging A/S Kontrastní prostředek a způsob jeho výroby
GB9504948D0 (en) * 1995-03-10 1995-04-26 Norwegian Radium Hospital Rese Compounds
JP4029440B2 (ja) 1997-07-09 2008-01-09 大日本インキ化学工業株式会社 側鎖型ラジカル重合性化合物及びそれを用いた液晶デバイス

Also Published As

Publication number Publication date
NO20042603L (no) 2004-06-21
DE60233819D1 (de) 2009-11-05
RU2350599C2 (ru) 2009-03-27
AU2002343086B2 (en) 2008-01-03
JP2005510556A (ja) 2005-04-21
CA2467773C (en) 2011-08-16
MXPA04004763A (es) 2004-07-30
GB0128052D0 (en) 2002-01-16
AU2002343086C1 (en) 2008-06-26
CA2467773A1 (en) 2003-06-05
US20050203181A1 (en) 2005-09-15
WO2003045893A1 (en) 2003-06-05
HUP0402122A2 (hu) 2005-02-28
AU2002343086A1 (en) 2003-06-10
JP4426298B2 (ja) 2010-03-03
US7629383B2 (en) 2009-12-08
KR20040071138A (ko) 2004-08-11
EP1448508A1 (en) 2004-08-25
RU2004118713A (ru) 2005-03-27
ATE443695T1 (de) 2009-10-15
EP1448508B1 (en) 2009-09-23
CN1589254A (zh) 2005-03-02

Similar Documents

Publication Publication Date Title
US20240156770A1 (en) High penetration prodrug compositions of retinoids and retinoid-related compounds
US20220064157A1 (en) Novel high penetration drugs and their compositions thereof for treatment of parkinson diseases
USRE50049E1 (en) Compositions and methods for treating psoriasis
US11541120B2 (en) Phosphonium-based ionic drug conjugates
CN102088956A (zh) 氯胍用于治疗皮肤/粘膜疾病
CN108239095A (zh) 一类吡喃并咔唑生物碱及其制备方法和其药物组合物与用途
JP2022503733A (ja) 口腔粘膜炎を治療するための方法および組成物
JP4426298B2 (ja) ダブルエステル
US20180221356A1 (en) Method of wound healing
TWI537245B (zh) 用於治療自體免疫發炎疾病之化合物
WO2004080455A1 (ja) 抗菌剤と抗ガン剤
TWI537246B (zh) 用於治療發炎性腸病之化合物
US20240109934A1 (en) Antibiotics with improved drug resistance profile
JPH05105627A (ja) 腸機能性疾患の治療に用いられる新規な医薬組成物と、その調整方法と、治療用医薬の調製方法
CZ2019743A3 (cs) Fenolické dihydrobenzofuranové deriváty, léčebné a kosmetické přípravky obsahující tyto deriváty a jejich použití
JP2020040949A (ja) パ−キンソン病治療用の新規高透過薬物及びその組成物
KR20220111039A (ko) Pep27 펩타이드로부터 유래한 신규 펩타이드 및 이의 용도
IT8922245A1 (it) Esteri dell'acido 6-d(-)-alfa-(4-etil-2, 3-diosso-1- piperazinilcarbonilamino)-alfa-fenilacetamido penicillanico, procedimento per la loro preparazione e relative composizioni farmaceutiche
MXPA06003008A (es) Farmaco antibacteriano para propionibacterium acnes

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090722

Termination date: 20201122

CF01 Termination of patent right due to non-payment of annual fee